Shuji Kaneko Selected Research

Neoplasms (Cancer)

1/2017	Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms.
12/2016	Development of a four-axis moving phantom for patient-specific QA of surrogate signal-based tracking IMRT.
10/2009	New algorithm to simulate organ movement and deformation for four-dimensional dose calculation based on a three-dimensional CT and fluoroscopy of the thorax.
6/2006	Heterologous expression of a mammalian ABC transporter in plant and its application to phytoremediation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuji Kaneko Research Topics

Disease

16	Pain (Aches) 01/2021 - 06/2006
10	Inflammation (Inflammations) 01/2022 - 07/2008
10	Hyperalgesia 01/2021 - 06/2008
8	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 07/2012
7	Hypersensitivity (Allergy) 01/2021 - 07/2012
6	Ischemia 01/2021 - 11/2002
5	Multiple Sclerosis 01/2022 - 05/2009
5	Brain Injuries (Brain Injury) 01/2021 - 05/2009
5	Neuralgia (Stump Neuralgia) 07/2018 - 12/2008
5	Cold Hypersensitivity 01/2018 - 07/2012
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 03/2015
4	Cystitis 02/2017 - 01/2013
4	Neoplasms (Cancer) 01/2017 - 06/2006
3	Mental Disorders (Mental Disorder) 01/2021 - 07/2013
3	Cognitive Dysfunction 01/2019 - 01/2018
2	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 01/2021
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 12/2019
2	Chronic Pain 01/2021 - 06/2008
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2008
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 10/2017
2	Memory Disorders (Memory Loss) 01/2018 - 01/2004
2	Hypoxia (Hypoxemia) 01/2018 - 03/2016
2	Paresthesia (Dysesthesia) 01/2017 - 03/2016
2	Wounds and Injuries (Trauma) 01/2017 - 04/2006
2	Gout 01/2017 - 11/2010
2	Diabetes Mellitus 01/2016 - 01/2010
2	Diabetic Neuropathies (Diabetic Neuropathy) 03/2015 - 01/2010
2	Infections 12/2013 - 07/2008
2	Gliosis 07/2013 - 09/2010
2	Seizures (Absence Seizure) 01/2012 - 02/2007
2	Alzheimer Disease (Alzheimer's Disease) 05/2009 - 08/2003
1	Bites and Stings (Sting) 01/2021
1	Tardive Dyskinesia 01/2021
1	Hyperkinesis 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Paralysis (Palsy) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Fibromyalgia (Fibrositis) 01/2020

Drug/Important Bio-Agent (IBA)

7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017 - 07/2012
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2004
6	AnkyrinsIBA 01/2018 - 01/2016
5	CytokinesIBA 01/2021 - 01/2010
5	ChemokinesIBA 01/2020 - 07/2008
5	PlatinumIBA 01/2017 - 07/2012
4	Analgesics (Analgesic Drugs)IBA 07/2018 - 01/2010
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2017 - 01/2013
4	Morphine (MS Contin)FDA LinkGeneric 01/2014 - 10/2007
4	Glutamic Acid (Glutamate)FDA Link 07/2013 - 10/2004
3	Streptozocin (Streptozotocin)FDA Link 01/2018 - 01/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 07/2012
3	CarrageenanIBA 03/2015 - 12/2008
3	Formaldehyde (Formol)FDA Link 03/2015 - 01/2007
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2014 - 07/2008
3	Thrombin FDA Link 07/2013 - 09/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 07/2008
3	Adenosine Triphosphate (ATP)IBA 06/2008 - 06/2006
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2022 - 12/2019
2	LipopolysaccharidesIBA 01/2021 - 10/2018
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2016
2	Biological ProductsIBA 12/2020 - 06/2006
2	Cocaine (Cocaine HCl)IBA 01/2020 - 01/2008
2	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 01/2018 - 07/2012
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 12/2017 - 01/2012
2	Oxygen (Dioxygen)IBA 10/2017 - 10/2004
2	Taxoids (Taxanes)IBA 01/2017 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 07/2012
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 03/2016 - 08/2011
2	OxalatesIBA 01/2016 - 07/2012
2	Serotonin (5 Hydroxytryptamine)IBA 04/2015 - 11/2007
2	Tramadol (K315)FDA LinkGeneric 01/2014 - 01/2014
2	Amitriptyline (Elavil)FDA LinkGeneric 01/2014 - 01/2014
2	Acetic Acid (Vinegar)FDA LinkGeneric 02/2009 - 01/2007
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2007 - 11/2002
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	5-HT2C Serotonin ReceptorIBA 01/2022
1	OxadiazolesIBA 01/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2021
1	lysophosphatidic acidIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Dopamine D2 Receptor AntagonistsIBA 01/2021
1	nepetalactolIBA 01/2021
1	OligodeoxyribonucleotidesIBA 01/2021
1	3-phenylcoumarinIBA 12/2020
1	LipidsIBA 12/2020
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 01/2020

Therapy/Procedure

7	Ligation 01/2021 - 12/2008
4	Intravesical Administration 02/2017 - 01/2013
3	Injections 01/2020 - 01/2007
2	Therapeutics 01/2018 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2017
2	Radiotherapy 03/2013 - 10/2009
1	Spinal Injections 01/2021
1	Castration 01/2020